BioSpace News Archive

Photocure ASA, the Bladder Cancer Company, announces that results from the Nordic Registry demonstrating benefits of Blue Light Cystoscopy were presented at the AUA 2023 Conference: the American Urological Association Annual Congress 2023 which was held April 28 - May 1, 2023 in Chicago, IL, USA.

Calibre Scientific, a leading global life science company, is pleased to announce the successful completion of the acquisition of the micro manipulation product portfolio from Eppendorf SE.

Ascletis Pharma Inc. announces that ASC40, a first-in-class, once-daily oral fatty acid synthase inhibitor, achieved primary and key secondary endpoints in Phase II clinical trial for acne vulgaris.

Syneos Health®, the only fully integrated biopharmaceutical solutions organization, announced the appointment of Michael Bonello as Chief Financial Officer, effective July 1, 2023.

Karuna Therapeutics, Inc. announced that management will present at the following upcoming investor conferences.

Harmony Biosciences Holdings, Inc. (“Harmony” or the “Company”) (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today reported financial results and business updates for the quarter ended March 31, 2023.

Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (Kiniksa), a biopharmaceutical company with a pipeline of immune-modulating assets designed to target a spectrum of cardiovascular and autoimmune diseases, today reported first quarter 2023 financial results and recent portfolio execution.

Ten63 Therapeutics, a company combining generative AI and physics-based models to develop first- and best-in-class therapeutics, today announced the closing of an oversubscribed $15.9 million Series A financing led by new investor Hatteras Venture Partners.

AVRICORE HEALTH INC. (TSXV: AVCR) (the " Company " or “ AVCR ”) today is pleased to announce its audited final results for 2022.

Hygieia is extending its Series B funding round to $22 million with a lead investment from Firstime Ventures and additional investment from two strategic partners.